Xcout Intel
ALTEOGEN
Alteogen is a biotechnology company that researches and develops next-generation bio-betters, biosimilars, and proprietary drug delivery platforms, including long-acting technologies, antibody-drug conjugates (ADCs), and subcutaneous injection conversion technologies. The company serves the global pharmaceutical and healthcare industries by developing advanced biologic drugs and platform solutions.
Subscribe to see ALTEOGEN’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ALTEOGEN at a glance
ALTEOGEN is a biotechnology company headquartered in South Korea. Xcout tracks 7 named people at ALTEOGEN, including 전태연 (대표이사(CEO), PhD, JD 사장).
ALTEOGEN leadership
- 전태연대표이사(CEO), PhD, JD 사장
- 김항연부사장, CFO(Chief Financial Officer)
- 이영필부사장, CPO, PhD
- Vivek ShenoyCBO, 해외사업 개발 담당, PhD, MBA
- 박순재회장, PhD
- 김규완부사장, 신약개발 담당
1 more named person on record for ALTEOGEN, with roles, board committees and tenure — see the full roster →
ALTEOGEN competitors
A few of ALTEOGEN's closest competitors — see the full list of competitors and alternatives →
LigaChem Biosciences is a clinical-stage biopharmaceutical company headquartered in Daejeon, South Korea. The company specializes in the discovery and development of novel therapeutics utilizing proprietary technology platforms such as antibody-drug conjugates. With decades of dedicated drug development experience, it drives global healthcare innovation through open collaboration.
Y-Biologics is a South Korea-based research and development biotechnology company headquartered in Daejeon. The firm focuses on developing novel antibody-based therapeutics using its proprietary platform technologies and pipelines.
IntoCell is a South Korean biotechnology company founded in 2015 and headquartered in Daejeon, specializing in drug-conjugate and related pharmaceutical technologies.
AbCellera is a biotechnology company that integrates biology, computation, and engineering to discover and develop antibody-based medicines. The company operates a proprietary technology platform to advance internal and partnered drug programs across therapeutic areas such as endocrinology, immunology, autoimmunity, and oncology.
Chimagen Biosciences is a biopharmaceutical company headquartered in Shanghai, China, founded in July 2016. The company specializes in multi-specific antibody therapeutics and built the proprietary TRIAD platform for engineering.
Evotec is a life science company that provides drug discovery and preclinical development services, working across modalities from small molecules to biotherapeutics. Through its subsidiary Just - Evotec Biologics, the company focuses on the design, development, and manufacturing of biologics to make therapies more accessible and affordable for partners in the pharmaceutical and biotechnology industries.
Get ALTEOGEN's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ALTEOGEN in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access